info@marketresearchfuture.com 📞 +1 628 258 0071(US)  📞 +44 2035 002 764(UK)
Global Controlled Release Drug Delivery Market Research Report - Global Forecast till 2027

Controlled Release Drug Delivery Market Research Report, by Route of administration (Transdermal, Oral), Release Mechanism (Polymer-based, Micro reservoir Partition), Products (Metered Dose Inhalers), End User (Hospital)— Forecast till 2027

ID: MRFR/Pharma/5330-HCR | February 2021 | Region: Global | 90 pages

Controlled Release Drug Delivery Market Speak to Analyst Request a Free Sample

Controlled Release Drug Delivery Market


The controlled release drug delivery market is predicted to attain a size of over USD 70.15 billion by the end of the forecast period. The report further suggests that the market will thrive at a CAGR of 14.0 % during the assessment era, says Market Research Future (MRFR).


Controlled release drug delivery is being used to offer a consistent amount of drug doses for a particular treatment. The technique offers several beneficial features and helps lower toxins accumulation due to heavy doses, decreases the frequency of drug administration, improves patient compliance, and stabilizes medical conditions. The global market for controlled release drug delivery has witnessed enormous growth in the last few years. The market's growth is mainly attributed to the increasing geriatric and pediatric population across the globe. Furthermore, factors such as the increasing government regulation to prevent overdose effects and rising prevalence of chronic diseases worldwide are also projected to impact the market's growth positively. On the other hand, the higher costs and possibility of less accuracy in adjusting the dosage impede the market's growth over the coming years.


Controlled Release Drug Delivery Market Segmentation:


The Controlled Release Drug Delivery Market is segmented on the basis of route of administration, release mechanism, products, and End Users.


By route of administration the market is segmented into oral, injectable, ocular, nasal, topical and implantable. The injectable is sub-segmented into targeted delivery, transmucosal, and transdermal. On the basis of the release mechanism, the market is segmented into polymer-based drug delivery systems, micro-reservoir partition-controlled drug delivery systems, feedback-regulated drug delivery systems, activation modulated drug delivery systems, and chemically activated controlled drug delivery systems. The activation modulated drug delivery systems are sub-segmented into osmotic pressure activated drug delivery, hydrodynamic pressure activated drug delivery, vapor pressure activated drug delivery, mechanically activated drug, magnetically activated drug. The chemically activated controlled drug delivery systems are sub-segmented into pH-activated drug delivery, hydrolysis activated drug delivery, enzyme activated drug delivery.


By product, the market is segmented into metered dose inhalers, needle-free injectors, auto-injectors, nasal sprays, transdermal patches, nebulizers, infusion pumps, drug-eluting stents, sustained release, and ocular implants. By end user, the market is segmented into hospital and clinics, personal use, research centers, and others.    


On the basis of region, the Global Controlled Release Drug Delivery Market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Key Players:


Some of the key players in the Global Controlled Release Drug Delivery Market are Depomed, Inc. (US), Coating Place, Inc.(US), Corium International Inc.(US), Alza Corporation (Johnson & Johnson)(US), Pfizer Inc.(US), SKY Pharmaceuticals Pvt. Ltd.(China), AstraZeneca (US),Biogen (US), GlaxoSmithKline (UK), Novartis (UK), Allergan (‎Ireland), Collegium Pharmaceutical (US) and Others.


Regional Market Summary Global Controlled Release Drug Delivery Market Share (%), by Region, 2017 Controlled Release Drug Delivery Market


Sources: National Cancer Institute, Cancer Research UK, the American Cancer Society, Inc, US Department of Health and Human Services National Institutes of Health


It is estimated that North America is expected to dominate the Global Controlled Release Drug Delivery Marketduring the forecasted period owing to the increasing prevalence of various disease such as gastrointestinal diseases (Crohn's disease and ulcerative colitis), Alzheimer’s etc., advance infrastructure in pharmaceutical industry, increasing research and development activity, and presence of big pharmaceutical companies in the region. According to the Centers for Disease Control and Prevention, estimated that 3 million of the US adults were diagnosed with inflammatory bowel disease (either ulcerative colitis or Crohn’s disease) in 2015. Such a high number of patients with gastrointestinal diseases may increase the demand for controlled release drug.


 Europe stood second largest in the Controlled Release Drug Delivery Market due to the increasing prevalence of respiratory diseases, high blood pressure or hypertension among the population. The Public Health England 2017 reported that around 2.1 million of the population below the age of 45 had high blood pressure in England in 2015. The increasing prevalence of hypertension and the cases of chronic diseases can boost the market during the forecasted period. 


 Asia-Pacific was anticipated to be the rapidly growing region for the controlled release drug delivery market. The market is likely to witness growth due to the increase in geriatric and pediatric population resulting in increasing demand for controlled doses to reduce the side effects and toxicity level in the patients. These factors may contribute to the market growth of controlled release drug in Asia-Pacific countries.


The Middle East and Africa holds low share in the global controlled release drug delivery market due to a fewer pharmaceutical industry with manufacturing units, low expenditure on healthcare, less awareness about the diseases and its treatments. However, the market is expected to observer growth due to increasing government funding on healthcare in the Middle East region.


Recent Developments


March 2022 – Innocan Pharma Corporation, a specialty pharmaceutical company, happily announced that Innocan's CBD LPT injection offered as a treatment for a dog going through osteoarthritis of the hip and elbow joint caused a reduction in pain and enhanced activity and vitality.


March 2022- Massachusetts General Hospital has announced the testing of Tonix Pharmaceuticals' nasally delivered potentiated oxytocin TNX-1900 to treat a continuous eating disorder. Tonix is developing TNX-1900 to treat chronic migraine.


March 2022 – a developer and manufacturer of innovative delivery formulations, Cure Pharmaceutical and Milagro Pharmaceuticals, have announced partnering with each other to register and sell some of CURE's OTC and medical compounds across Mexico. The compounds use CURE's patented drug delivery platform for oral thin film (OTF), CUREform™.


Intended Audience:



  • Government and private laboratories

  • Hospitals and Clinics

  • Research Centers

  • Pharmaceutical manufacturers

  • Biopharmaceutical companies

  • Contract laboratories

  • Authorities


Segmentation and Key Market Players:


Controlled Release Drug Delivery Market, by Route of Administration:



  • Oral

  • InjectableTargeted Delivery

    • Transmucosal

    • Transdermal

    • Ocular



  • Nasal

  • Topical

  • Implantable


Controlled Release Drug Delivery Market, by Release Mechanism:    



  • Polymer-based Drug Delivery Systems

  • Micro reservoir Partition Controlled Drug Delivery Systems

  • Feedback Regulated Drug Delivery Systems

  • Activation Modulated Drug Delivery Systems

    • Osmotic Pressure Activated drug delivery

    • Hydrodynamic Pressure Activated drug delivery

    • Vapor Pressure Activated drug delivery

    • Mechanically Activated drug

    • Magnetically Activated drug



  • Chemically Activated Controlled Drug Delivery Systems

    • pH Activated Drug Delivery

    • Hydrolysis Activated Drug Delivery

    • Enzyme Activated Drug Delivery




Controlled Release Drug Delivery Market, by Products:



  • Metered Dose Inhalers,

  • Needle-Free injectors

  • Auto-injectors

  • Nasal sprays

  • Transdermal Patchez

  • Nebulizers

  • Infusion Pumps

  • Drug Eluting Stents

  • Sustained Release

  • Ocular Implants


 Controlled Release Drug Delivery Market, by End Users:



  • Hospital and Clinics

  • Personal Use

  • Research Centers

  • Others


Controlled Release Drug Delivery Market, by Region:



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa



Speak to Analyst Ask for Customization